65 completed, 11 unknown, 9 not yet recruiting, 3 active not recruiting. 29 Phase 3, 19 Phase 2, 15 Not applicable, 14 Phase 1, 12 Phase 4.
Follow Rhabdoviridae Infections: new trials by email Literature Review of Rhabdoviridae Infections trials Research Report on Rhabdoviridae Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Boostability Assessment of Three Rabies Pre-Exposure Regimens in Healthy Volunteers 5 Years Following Priming. Booster vaccination - Rabies (Healthy Volunteers) | Phase 3 | Not yet recruiting | Institute of Tropical Medicine, Belgium | 561 | 2026-05-15 | 2026-03-06 |
| Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine Sinovac rabies vaccine - Rabies (Healthy Volunteers) | Phase 3 | Not yet recruiting | Sinovac Biotech Co., Ltd | 912 | 2026-03-04 | 2026-02-17 |
| Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen Rabies Vaccine (Serum-free Vero Cell), Freeze-dried, Verorab® - Rabies | Phase 3 | Not yet recruiting | Sinovac Biotech Co., Ltd | 390 | 2026-03-01 | 2025-07-08 |
| Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen Rabies vaccine, Verorab® - Rabies (Healthy Volunteers) | Phase 3 | Not yet recruiting | Sinovac Biotech Co., Ltd | 390 | 2026-03-01 | 2025-07-09 |
| A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10 to 60 Years Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried - Rabies | Phase 3 | Active not recruiting | Ab&B Bio-tech Co., Ltd.JS | 3000 | 2026-02-26 | 2026-10-28 |
| A Phase II Trial of a Recombinant Human Anti-Rabies Virus Monoclonal Antibody Recombinant Human Rabies Virus Monoclonal Antibody Injection, Human Rabies Immunoglobulin (HRIG), Placebo - Rabies (Healthy Volunteers) | Phase 2 | Not yet recruiting | Lanzhou Institute of Biological Products Co., Ltd | 200 | 2026-01-31 | 2026-03-03 |
| Safety and Immunogenicity of ID vs IM Rabies Vaccine Rabies vaccine - Rabies | Phase 2 / Phase 3 | Not yet recruiting | International Centre for Diarrhoeal Disease Research, Bangladesh | 90 | 2025-12-15 | 2026-01-15 |
| Safety and Immunogenicity of Coadministration of the Candidate Rabies Vaccine ChAdOx2 RabG and Licensed Vaccine Coadministration of ChAdOx2 RabG and licensed inactivated rabies vaccine (IRV), Inactivated Rabies Vaccine (IRV) - Rabies | Phase 2 | Not yet recruiting | University of Oxford | 40 | 2025-12-01 | 2025-11-18 |
| Real World Evidence Study of SYN023 in Children Exposed to Rabies Rabies Post-exposure Prophylaxis | Recruiting | Synermore Biologics (Suzhou) Co., Ltd. | 232 | 2025-08-02 | 2026-04-23 | |
| Clinical Trial of Freeze-dried Human Rabies Vaccine (Human Diploid Cells) Freeze-dried human rabies vaccine (human diploid cells) - Rabies | Phase 3 | Not yet recruiting | Ningbo Rongan Biological Pharmaceutical Co., Ltd. | 3000 | 2025-07-31 | 2025-06-19 |
| Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell) Rabies Vaccine (Serum-free Vero Cell), Freeze-dried, Verorab® - Rabies | Phase 2 | Not yet recruiting | Sinovac Biotech Co., Ltd | 120 | 2025-07-28 | 2025-07-09 |
| Real-World Effectiveness of Zamerovimab and Mazorelvimab and Vaccine for Rabies Grade III Exposure in Nanyang Zamerovimab and Mazorelvimab Injection plus Rabies Vaccine - Rabies Post-exposure Prophylaxis, Rabies | Active not recruiting | Synermore Biologics (Suzhou) Co., Ltd. | 80 | 2025-06-06 | 2026-06-11 | |
| Adherence to Anti-rabies Post-exposure Prophylactic Protocols survey - Rabies | Completed | Tanta University | 214 | 2025-06-01 | 2026-03-30 | |
| A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried Freeze-dried Human Rabies Vaccine（Human Diploid Cell）, Essen, Freeze-dried Human Rabies Vaccine（Human Diploid Cell），Zagreb - Rabies | Phase 1 | Recruiting | Ningbo Rongan Biological Pharmaceutical Co., Ltd. | 60 | 2025-05-23 | 2025-06-15 |
| SYN023 With Rabies Vaccine in Healthy Pediatric Subjects SYN023, Rabies Vaccine, HRIG - Rabies Post-exposure Prophylaxis | Phase 1 | Completed | Synermore Biologics (Suzhou) Co., Ltd. | 108 | 2024-11-30 | 2026-01-15 |
| Rabies mAb CBB 1 Combination Vaccine in Healthy People With Antibody Neutralization Activity and Safety Phase Clinical Trials Natural full human monoclonal antibody CBB 1 injection 50.0µg/kg, Natural full human monoclonal antibody CBB 1 injection 100.0µg/kg, Rabies Human Immunoglobulin (HRIG) - Rabies Virus Infection | Phase 2 | Unknown | Changchun BCHT Biotechnology Co. | 120 | 2024-07-31 | 2024-08-12 |
| A Trial to Evaluate the Safety and Immunogenicity of an Investigational Vaccine for the Prevention of Yellow Fever, and of an Investigational Vaccine for the Prevention of Rabies, in Healthy Adults AVX70120 low dose level, AVX70120 middle dose level, AVX70120 high dose level - Yellow Fever, Rabies | Phase 1 | Completed | AstriVax Therapeutics | 112 | 2024-06-16 | 2026-04-22 |
| A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried in a Population Aged 10-60 Years Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried - Rabies | Phase 1 | Completed | Ab&B Bio-tech Co., Ltd.JS | 80 | 2023-11-27 | 2026-01-02 |
| A Study to Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried PIKA Rabies Vaccine (Vero Cell) for Human use, Freeze-dried, Chirorab - Rabies, Prevention | Phase 3 | Unknown | Yisheng Biopharma (Singapore) Pte. Ltd. | 4500 | 2023-09-22 | 2024-07-23 |
| Clinical Trial of Freeze-dried Human Rabies Vaccine (Without Serum Vero Cells) 5-dose group of test vaccine, 5-dose group of control vaccine, 4-dose A group of test vaccine - Rabies | Phase 3 | Unknown | Ningbo Rongan Biological Pharmaceutical Co., Ltd. | 2460 | 2023-08-01 | 2023-08-09 |
Showing 20 of 95. Sign in to see all of them.
Rabies (95) · Virus Diseases (4) · Encephalitis, Japanese (3) · Yellow Fever (2) · COVID-19 (1) · Communicable Diseases (1) · Diarrhea (1) · Encephalitis (1) · Fever (1) · Health Education (1) · Meningitis, Meningococcal (1) · Meningococcal Infections (1) · Mononegavirales Infections (1) · Obesity (1) · RNA Virus Infections (1)
Infections (95) · Mononegavirales Infections (94) · RNA Virus Infections (94) · Virus Diseases (91) · Arbovirus Infections (4) · Brain Diseases (4) · Central Nervous System Diseases (4) · Flaviviridae Infections (4) · Flavivirus Infections (4) · Mosquito-Borne Diseases (4) · Nervous System Diseases (4) · Neuroinflammatory Diseases (4) · Vector Borne Diseases (4) · Central Nervous System Infections (3)
Rabies Vaccines (29) · Freeze Drying (3) · PIKA adjuvant (2) · Vaccines (2) · Albumins (1) · Blood Specimen Collection (1) · COVID-19 Vaccines (1) · Caprylates (1) · Chloroquine (1) · Doxycycline (1) · Floors and Floorcoverings (1) · Immunization, Secondary (1) · Japanese Encephalitis Vaccines (1) · MenACWY-CRM vaccine (1) · Surveys and Questionnaires (1)
Sanofi Pasteur, a Sanofi Company (11) · Queen Saovabha Memorial Institute (9) · Novartis Vaccines (6) · Sinovac Biotech Co., Ltd (5) · Synermore Biologics (Suzhou) Co., Ltd. (5) · Crucell Holland BV (3) · CureVac (3) · GlaxoSmithKline (3) · Ningbo Rongan Biological Pharmaceutical Co., Ltd. (3) · University of Oxford (3) · Yisheng Biopharma (Singapore) Pte. Ltd. (3) · Ab&B Bio-tech Co., Ltd.JS (2) · Changchun BCHT Biotechnology Co. (2) · Institute of Tropical Medicine, Belgium (2) · Jiangsu Province Centers for Disease Control and Prevention (2)
China (25) · United States (15) · Thailand (14) · Germany (6) · Pakistan (5) · Philippines (5) · Belgium (4) · India (4) · Austria (2) · France (2) · Singapore (2) · Switzerland (2) · Tanzania (2) · Vietnam (2) · Bangladesh (1)
Suda Sibunruang, MD (6) · Alexander D Douglas (3) · Limin Wijaya (2) · Ume Sughra, Dr. (2) · Ali Faisal Saleem (1) · Beatriz P. Quiambao, MD (1) · C. James Kissling, MD (1) · Chaolin Huang (1) · Darryn Knobel, PhD (1) · Franz-Josef Falkner von Sonnenburg, MD (1)
PMID 25483635, PMID 37821317, PMID 17643772, PMID 20945113, PMID 21752947, PMID 22211130, PMID 23510665, PMID 24148575, PMID 24873986, PMID 25308927, PMID 25692350, PMID 25692792, PMID 26005163, PMID 26994987, PMID 28118938, PMID 28754494, PMID 29116846, PMID 29174316, PMID 29939243, PMID 29983597, PMID 30574495, PMID 30890382, PMID 31743394, PMID 31802120, PMID 32546199, PMID 32732723, PMID 32943430, PMID 33024152, PMID 33091433, PMID 33487468, PMID 33847527, PMID 33945439, PMID 34127294, PMID 34483020, PMID 35778281, PMID 35906106, PMID 35907430, PMID 36016106, PMID 36123259, PMID 38478634, PMID 38834432, PMID 39418686, PMID 39587931, PMID 39927222, PMID 40479926, PMID 40812204, PMID 42066780, PMID 42764163
2015 (1), 2017 (1), 2018 (1), 2019 (1), 2025 (1)